Alain Parthoens

Prepare for Meeting →

Managing Partner

Vesalius Biocapital

Check size: Vesalius Biocapital does not publish a standard current check-size range on its official site.

Investment Thesis

Alain Parthoens invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical devices and digital health with active strategic support.

What Excites Them

Experienced teams translating differentiated science or health technology into products with clear clinical and commercial value.

What They Pass On

Opportunities outside life sciences and healthcare, or without credible scientific and development evidence, are less aligned.

How to Pitch

Present the science, validation, intellectual property, clinical need, regulatory path, market and financing milestones.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Alain Parthoens is a current Managing Partner at Vesalius Biocapital, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal